Silygamma 150mg Worwag treatment for chronic hepatitis, cirrhosis (4 blisters x 25 tablets)

Dosage form Tablet
Specifications Box of 4 blisters x 25 tablets
Ingredient Silymarin
Indication Cirrhosis, chronic hepatitis
Contraindication Drug allergy

Ingredient

Composition information	Content
Silymarin	150mg

Uses

Indications

Silygamma drug is indicated in the following cases:

Support the treatment of chronic hepatitis, cirrhosis and liver damage due to poisoning. free radicals. In this way, the pathology of lipid percide - responsible for the destruction of cell membranes, will be interrupted or prevented. In addition, Silymarin will stimulate protein synthesis and normalize phospholipid metabolism in previous liver cells.

In short, as a result, the cell membrane is stable and the phenomenon of losing the soluble products of liver cells (such as transaminase enzymes) will be inhibited and prevented.

Silygamma will inhibit liver toxic substances (such as cellular toxins) as soon as these substances enter the cell.

Silygamma increases the synthesis of protein based on the activity of RNA polymerase-l right in the cell nucleus leading to an increase in the formation of ribosome RNA. Therefore, the synthesis of structural protein molecules and enzymes (enzymes) is increased. In short, the ability to recover and regenerate the liver is increased.

Dynamic pharmacology

Silygamma is a mixture of syribinins, sylidianin, sylichristin and some other flavonol derivatives extracted from hemp.

After absorbing through the gastrointestinal tract, the main ingredient of silymarin is the siiBinin eliminated up to more than 80% in the bile in the form of sulphate and glucoronide complex. About 10% of the dose of use goes into the hepatic circulatory round, so the maximum content in the blood is relatively low.

Sell waste time is 6.3 hours. There is no accumulation of syriinin. Silibinin excretion reaches equilibrium when the dose is repeated at the latest on the 2nd day.

Before taking Silygamma 150mg Worwag treatment for chronic hepatitis, cirrhosis (4 blisters x 25 tablets)

How to use

Silygamma 150mg drug used orally, can be used when hungry or full.

Dosage

Adults and teenagers aged 12 years and older: 1 capsule, 2 times a day, drink with sufficient amount of water (about 1 cup) before or during meals unless otherwise specified.

The doctor decides the treatment time.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when using overdose? The undesirable reactions described above may occur with more severe levels. If there is suspicion of overdose, please contact the doctor.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using SilyGamma you can experience unwanted effects (ADR).

Digestive problems, such as rare mild removal effects when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Silygamma drugs are contraindicated in cases where there is a history of sensitivity to the milk thistle or with the plants of the chrysanthemum family or with any ingredients of the drug.

Caution when used

This drug contains lactose, so patients with galactose intolerance due to rare genetics, lactase deficiency or glucose-galactose should not be used in SilyGamma. In parallel with the drug treatment must be away from the causes of liver damage (alcohol).

Must notify the doctor cases of jaundice (the skin color change from light yellow to dark, white eyes are yellow).

There are no adequate studies in children. Therefore SilyGamma is not used for children younger than 12 years old.

The ability to drive and operate machinery

No.

Pregnancy

Do not use silygamma for pregnant women.

Breastfeeding period

Do not use silygamma for breastfeeding women due to lack of appropriate studies.

Drug interaction

Silymarin reduces the activity of the enzyme CYP3A4 in vitro.

If using Silymarin along with the metabolic drugs by the CYP3A4 enzyme, it may change the pharmacokinetics of those drugs.

The influence of other isenzymes in the cytochrome P450 enzyme system must also be considered.

Silical studies on Silygamma have not been reported. However, it should be monitored when using SilyGamma simultaneously with drugs with the above characteristics.

Storage

Store at temperatures below 30 ° C, in the original packaging and avoid light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.